Blood stored longer may be less safe for patients with massive blood loss and shock

March 10, 2018, University of Alabama at Birmingham
The researchers from left: Brant M. Wagener, Jean-Francois Pittet and Rakesh Patel. Credit: UAB

Human blood from donors can be stored for use up to 42 days, and it is a mainstay therapy in transfusion medicine. However, recent studies looking back at patient records have shown that transfusion with older, stored blood is associated with adverse effects.

For severely injured patients who have massive bleeding and receive many transfusion units, older blood was associated with dysfunction in blood flow, increased injury and inflammation in critical end organs, and lung infection.

In a collaborative study using a mouse model, University of Alabama at Birmingham researchers from the departments of Anesthesiology and Perioperative Medicine, Biostatistics, Emergency Medicine, Pathology, and Surgery have found mechanistic links between older stored red blood cell transfusions and subsequent bacterial pneumonia.

This may reveal new approaches to improve safety of stored red blood cell transfusions.

The key player is free heme, a breakdown product from degraded . Heme is part of the oxygen-binding hemoglobin pigment that gives blood cells their red color and carries oxygen through the body from the lungs. While in the red blood cell, heme is relatively safe; but once outside the confines of the red cells, free heme is toxic and can cause tissue injury. During storage and upon transfusion, stored red blood cells lyse open, releasing free heme.

An adverse role for heme suggests that finding ways to limit heme exposure or prevent heme toxicity may improve safety of stored red blood cell transfusions, say UAB researchers Rakesh Patel, Ph.D., and Jean-Francois Pittet, M.D.

Patel is a professor of pathology and director of the Center for Free Radical Biology, and Pittet is a professor of anesthesiology and perioperative medicine at the UAB School of Medicine.

In a study led by Patel and Pittet and published in the journal PLOS Medicine, mice were resuscitated after trauma and hemorrhage, using either fresh or two-week-old stored blood. Two days later, they were challenged by instilling the lungs with the bacteria Pseudomonas aeruginosa. A two-week storage of mouse blood approximates storage of human red blood cells for 42 days.

Compared to fresh blood, resuscitation with the stored blood significantly increased bacterial lung injury, as shown by higher mortality, and increases in fluid accumulation and bacterial numbers in the lungs.

A connection between free heme and infection susceptibility and severity was shown two ways. First, Pseudomonas aeruginosa-induced mortality was completely prevented by the addition of hemopexin, a scavenging protein in humans that removes free heme from the blood.

Second, adding an inhibitor of a called toll-like receptor 4, or genetically removing that receptor from mice, also prevented the bacteria-induced mortality. Free heme—which is known to induce inflammatory injury to major organs in diseases like sickle cell or sepsis—acts, in part, by activating the toll-like receptor 4.

The researchers also found that transfusion with stored blood induced release of the inflammation mediator HMGB1, part of the body's immune response.

In tissue culture experiments, Patel, Pittet and colleagues found that addition of free heme increased permeability in a sheet of endothelial cells, and free heme inhibited macrophages from ingesting Pseudomonas aeruginosa. Macrophages are immune cells that remove infection by ingesting and destroying bacteria.

Finally, in a 16-month study, the researchers found that human trauma-hemorrhage patients who received large amounts of transfused blood were also receiving amounts of free heme sufficient to overwhelm the normal amounts of hemopexin found in a person's blood.

"We recognize that many challenges and questions remain and view our data as hypothesis-generating," Patel, Pittet and colleagues said. "Clinically, our findings underscore the need to establish whether the storage age of transfused red correlates with increasing levels of free heme after , and whether low ratios of hemopexin to free heme will identify patients at greater risk for adverse outcomes after massive transfusions."

Explore further: Protecting transplanted lungs

More information: Brant M. Wagener et al, Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study, PLOS Medicine (2018). DOI: 10.1371/journal.pmed.1002522

Related Stories

Protecting transplanted lungs

February 13, 2018
Primary graft dysfunction (PGD)—acute lung injury that develops within 72 hours of lung transplantation—is a major cause of illness and death after transplant. The mechanisms leading to PGD are not well understood, and ...

'Cleaner' protein protects against atherosclerosis

February 3, 2015
We have an innate mechanism that ensures that our blood vessels do not become blocked. The protein A1M, alpha-1-microglobulin, is naturally present in the body and prevents oxidation of blood fats—a major cause of atherosclerosis. ...

Risks associated with receipt of blood transfusion from previously pregnant donor

October 17, 2017
Among patients who received red blood cell transfusions, receiving a transfusion from a donor who was ever pregnant, compared with a male donor, was associated with an increased risk of death among male recipients of transfusions ...

Is older blood OK to use in a transfusion?

September 27, 2017
(HealthDay)—Using older red blood cells to give transfusions to critically ill patients doesn't appear to affect their risk of dying, Australian researchers report.

Pretreating red blood cells with nitric oxide may reduce side effect linked to transfusions

November 7, 2016
A new treatment may diminish a dangerous side effect associated with transfusions of red blood cells (RBCs) known as pulmonary hypertension, an elevated blood pressure in the lungs and heart that can lead to heart failure, ...

Recommended for you

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Surgeon performance benefits from 'warm-up'

March 20, 2018
Surgeons progressively 'warm-up' as they repeat a procedure on their operating list, akin to the way athletes' performance improves across a competition—according to new research.

Blood stored longer may be less safe for patients with massive blood loss and shock

March 10, 2018
Human blood from donors can be stored for use up to 42 days, and it is a mainstay therapy in transfusion medicine. However, recent studies looking back at patient records have shown that transfusion with older, stored blood ...

After knee replacement, play on

March 8, 2018
(HealthDay)—Knee replacement patients can continue to enjoy sports—such as skiing, tennis and dancing—without worrying that high-impact activities might compromise their new joint, a small, new study finds.

Engineered cartilage template to heal broken bones

March 8, 2018
A team of UConn Health researchers has designed a novel, hybrid hydrogel system to help address some of the challenges in repairing bone in the event of injury. The UConn Health team, led by associate professor of orthopedic ...

Treating hypothyroidism to stop a stubborn surgical complication

March 7, 2018
Researchers at the University of Michigan have discovered a link between low thyroid hormone levels and wound healing complications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.